Presented Abstracts

Poster Session I
Renal - Basic Research & Imaging

Hall Oranje Zaal

Moderators: Christoph Klingler - Raymond Leveillee

P-01
Rationale for a less aggressive therapy for small renal tumors
Tsivian M., Mouraviev V., Kimura M., Mayes J.M., Albala D.M., Robertson C.N., Walther Ph.J., Polascik Th.J.
Duke University Medical Center, Durham, USA

P-02
The prognostic significance of tumor diameter in incidentally detected small renal masses
Decoene J., De Wil P., Van Poppel H., Joniau S.
Department of Urology, University Hospital Leuven, Belgium

P-03
Renal function after nephron sparing surgery and radical nephrectomy in elective cases
De Wil P., Decoene J., Van Poppel H., Joniau S.
Department of Urology, University Hospitals Leuven, Belgium

P-04
Radiofrequency and microwave in albumin
Salas N.^(1,2), Leveillee R.J.^(1,2), Dummett S.^(1,2), Aguilar M.⁽³⁾
(1) Joint Biomedical and Endourology Developmental Surgical (JBEDS) Laboratory, Division of Endourology, Laparoscopy, and Minimally-Invasive Surgery, Department of Urology, University of Miami Miller School of Medicine, Miami, FL, USA;
(2) Department of Biomedical Engineering, College of Engineering, University of Miami, Coral Gables, FL, USA;
(3) Ophthalmic Biophysics Center, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA

P-05
Impact of Pneumoperitoneum on Iceball Size in Renal Cryotherapy
Jennifer L. Young, Cervando G. Ortiz-Vanderdys, David W. McCormick, Victor B. Huynh, Adam G. Kaplan, Nick S. Jain, Donald L. Pick, Michael K. Louie, Lorena A. Andrade, Kathryn E. Osann, Elspeth M. McDougall and Ralph V. Clayman
University of California, Irvine, USA

P-06
Ice Burn: Protecting the Flank during Renal Cryotherapy
Young J.L., Kolla S.B., Pick D.L, Sountoulides P., Kaufmann O.G., Huynh V.B., Kaplan A.G., Ortiz-Vanderdys C.G., Louie M.K., Andrade L.A., Osann K.E., McDougall E.M., Clayman R.V.
University of California, Irvine, USA

P-07
Are multiple cryoprobes additive or synergistic in renal cryotherapy?
Young J.L., McCormick D.W., Kolla S.B., Ortiz-Vanderdys C.G., Huynh V.B., Kaplan A. G., Jain N. S., Pick D. L., Andrade L. A., Osann K. E, McDougall E. M. Clayman R. V.
University of California, Irvine, USA

P-08
In vitro, Ex vivo and In Vivo Isotherms for Renal Cryotherapy
Young J. L., Kolla S. B., Pick D. L., Osann K. E., Sountoulidis P., Kaufmann O. G., Ortiz-Vanderdys C. G., Kaplan A. G., Huynh V. B., McDougall E. M. and Clayman R. V.
University of California, Irvine, USA

P-09
Advanced techniques in renal RFA
Butani D., Moorthy M., Erturk E. , Saad W. , Kitanosono T. , Sasson T. , Waldman D.
University of Rochester, Rochester, USA

P-10
Predictive Factors for CKD after Curative Surgery in Small Kidney Tumors
Lee E., Jeon W.G., Bae J.B., Lee S.E.
Department of Urology, Seoul National University Hospital, Seoul, Korea

P-11
Irreversible electroporation in in-vivo porcine kidneys
Leveillee R.J.^(1,2), Salas N.^(1,2), Jorda M.⁽³⁾, Moore C.⁽¹⁾, Sierra M.E.⁽³⁾, Shields J.⁽¹⁾
(1) Joint Bioengineering and Endourology Developmental Surgical Laboratory, Division of Endourology, Laparoscopy, and Minimally-Invasive Surgery, Department of Urology, University of Miami Miller School of Medicine, Miami, FL, USA;
(2) Department of Biomedical Engineering, University of Miami, Coral Gables, FL, USA;

(3) Department of Pathology, University of Miami Miller School of Medicine, Miami, FL, USA

P-12
Synchronised real-time ultrasound and 3d CT scan navigation during percutaneous renal cryoablation
Haber G.P., Crouzet S., Colombo J.R., Remer E., O'Malley C., Ukimura O., Magi-Galluzzi C., Spaliviero M., Kaouk J.H.
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, USA

P-13
Notes (natural orifice translumenal endoscopic surgery) renal cryoablation in the porcine model
Crouzet S.⁽¹⁾, Haber G.P.⁽¹⁾, Kamoi K.⁽¹⁾, Brethauer S.⁽²⁾, Gatmaitan P.⁽²⁾, Kaouk J.⁽¹⁾
(1) Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland
(2) Bariatric and Metabolic Institute, Cleveland Clinic, Cleveland, USA

P-14
The role of multi-slice computer tomography with 3D reconstruction in the nephron-sparing management of renal tumors
Bucuras V.⁽¹⁾, Bardan R.⁽¹⁾, Comsa C.⁽¹⁾, Jude C.⁽¹⁾, Secasan C.⁽¹⁾, Miclaus G.⁽²⁾
(1) Department of Urology, Clinical Emergency Hospital, Timisoara, Romania,
(2) Neuromed Imaging Clinic, Timisoara, Romania

Poster Session II
Renal Treatment - Focal Therapies

Hall Windsor Zaal

Moderators: Francis Keeley (UK) – Andreas Skolarikos (GR)

P-15

Technology and therapy: Paradigm shifts in the treatment of renal cancer -University of California Irvine Experience
Sountoulides P., Louie M.K., Pick L.D, Kaufmann O.G., Lee H., McDougall E., Ornstein D., Dash A., Ralph V. Clayman R.V.
Urology Department, University of California, Irvine, USA

P-16
Percutaneous Radiofrequency ablation of renal cell carcinoma: follow up in patient with increased comorbidity
Brehmer B., Firek P., Mahnken A.H., Heidenreich A.
Urologic University Clinic Aachen, Germany

P-17

Radiofrequency ablation and cryoablation for renal tumours: systematic review of complications and intermediate-term outcome results
Joniau S., Van Haute C., Oyen R., Van Poppel H.
Department of Urology, University Hospital, K.U. Leuven, Leuven, Belgium

P-18

Results of RFA in patients with small renal masses, a single-centre experience with median follow-up of 48 months
Joniau S., Tailly Th., Goeman L., Oyen R., Van Poppel H.
Department of Urology, University Hospital Leuven, Leuven, Belgium

P-19
Radiofrequency ablation versus nephron-sparing surgery in the treatment of small renal tumors in patients with a solitary kidney: matched analysis of 29 patients
Van Den Bossche H., Tailly Th., Arun J., Oyen R., Van Poppel H., Joniau S.
Department of Urology, University Hospital Leuven, Leuven, Belgium

P-20

Radiofrequency ablation of small renal masses: Prognostic implications of a history of RCC and solitary kidney
Tailly Th., Oyen R., Van Poppel H., Joniau S.
Department of Urology, University Hospital Leuven, Leuven, Belgium

P-21
Percutaneous salvage radio-frequency ablation (RFA) for post-chemotherapeutic metastatic germ cell tumors and metastatic kidney cancer
Terukazu Nakamura, Akihiro Kawauchi, Takuji Yamagami, Kazuya Mikami, Natsuki Takaha, Osamu Ukimura, Tsunehiko Nishimura, Tsuneharu Miki
Department of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan

P-22
Laparoscopic and percutaneous cryoablation for renal tumors: a two-institution experience
Polascik T.J.⁽¹⁾, Tsivian M.⁽¹⁾, Mayes V.⁽¹⁾, Mouraviev V.⁽¹⁾, Wynia B.⁽²⁾ ,Shingleton B.⁽²⁾
(1) Division of Urology, Department of Surgery, Duke University Medical Center, Durham, NC, USA
(2) University of North Carolina, Chapel Hill, NC, USA

P-23
Laparoscopic cryoablation of small renal masses
Gulur D.M., Chua W.J., Kumar V., Keeley Jr. F.X.
Bristol Urological Institute, Westbury on Trym, Bristol, United Kingdom

P-24
Ultrasound-guided cryotherapy of prostate and kidney cancer in day surgery
Larsen U.T.⁽¹⁾, Felsby S.⁽¹⁾, Borre M.⁽²⁾, Solvig J.⁽³⁾, Bjerklund Johansen T.E.⁽²⁾
(1) Department of Anaesthesiology and Intensive Care, Day Surgical Clinic
(2) Department of Urology
(3) Department of Diagnostic Imaging and Radiology. Aarhus University Hospital Skejby, Denmark

P-25
Laparoscopic versus percutaneous renal cryoablation
Crouzet S., Haber G.P., Kamoi K., Goel R., Kaouk J.
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, USA

P-26
Tumor in solitary kidney: laparoscopic partial nephrectomy versus laparoscopic cryoablation
Crouzet S., Haber G.P., Kamoi K., Gill I.S., Kaouk J.
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, USA

P-27
Single Port Access Renal Cryoablation
Crouzet S., Goel R.K., Haber G.P., White W., Kaouk J.H.
Glickman Urological and Kidney Institute , Cleveland Clinic, Cleveland, USA

P-28
Stereotactic percutaneous cryoablation for renal tumor
Haber G.P., Crouzet S., O'Malley C., Remer E., Kamoi K., Goel R.K., White W., Kaouk J.H.
Glickman Urological and Kidney Institute , Cleveland Clinic, Cleveland, USA

P-29

Tumor size and endophytic growth pattern affect recurrence rates after laparoscopic renal cryoablation
Tsivian M.⁽¹⁾, Lyne J.⁽²⁾, Mayes J.M.⁽¹⁾, Mouraviev V.⁽¹⁾, Kimura M.⁽¹⁾, Thomas J Polascik⁽¹⁾(1) Duke University Medical Center, Durham, USA
(2) Allegheny General Hospital, Pittsburgh, USA

P-30
Feasibility kidney ablation MR guided radiotherapy
Kerkhof E.M.⁽¹⁾, Raaymakers B.W.⁽¹⁾, van Vulpen M.⁽¹⁾, Zonnenberg B.A.⁽²⁾,
Bosch J.L.H.⁽³⁾, Lagendijk J.J.W.⁽¹⁾
(1) Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
(2) Department of Internal Medicine, University Medical Center Utrecht, Utrecht, The Netherlands
(3) Department of Urology, University Medical Center Utrecht, Utrecht, The Netherlands

P-31
Perioperative morbidity of laparoscopic renal cryoablation: a multicentre experience
Laguna M.P.⁽¹⁾, Beemster P.⁽¹⁾, Kumar V.⁽²⁾, Klingler C.⁽³⁾, Wyler S.⁽⁴⁾, Anderson C.⁽⁵⁾, Keeley F. X.⁽²⁾, Bachmann A.⁽⁴⁾, Rioja J.⁽¹⁾, Mamoulakis C.⁽¹⁾, Marberger M.⁽³⁾,
de la Rosette J.J.⁽¹⁾
(1) Department of Urology, AMC University Hospital, Amsterdam, The Netherlands, (2)Bristol Urological Institute, Southmead Hospital, Bristol, UK, Department of Urology, (3)Medical University of Vienna, Vienna, Austria,
(4) Department of Urology, University Hospital of Basel, Basel, Switzerland,
(5) Department of Urology, St George’s Hospital, London, UK

P-32
Design of a unique loosely wound radiofrequency coil for tumour ablation
Sherar M.D.^(1,2) Weersink R.⁽¹⁾, Zhang K.⁽¹⁾, Zuniga A.^(1,2), McCann C.⁽¹⁾, Taylor M.⁽¹⁾, Jewett M.A.S.^(1,2)
(1) Princess Margaret Hospital/University Health Network;(2) University of Toronto

Poster Session III
Prostate Basic Research & Imaging

Hall Imperial Bar

Moderators: Jens Rassweiler (DE) - Santiago Isorna Martinez de la Riva (ES)

P-33
Is focal therapy an option for the majority of localised prostate cancer? A histopathological study of contemporary UK Radical Prostatectomies series
Aslam M., Kheradmund F., Turner G., Brewster S. F.
Oxford Radcliffe Hospitals , Oxford, UK

P-34
Incidental prostate cancer. A malignancy while treating a benign disease
Xoxakos I.⁽¹⁾, Sotiropoulou G.⁽²⁾, Rompolis D.⁽¹⁾, Chatzinicolaou V.⁽²⁾, Kalyvas Ch.⁽¹⁾,
Louka G.⁽¹⁾, Stokidis D.⁽¹⁾
(1) Department of Urology, General Hospital of Korinthos,Greece
(2) Department of Pathology, General Hospital of Korinthos,Greece

P-35
Transrectal ultrasound prostate volume at biopsy predicts clinically significant upgrading after radical prostatectomy
Seung Chol Park, Hyung-Lae Lee⁽¹⁾, Tae Gyun Kwon⁽²⁾, Sang Hyun Cheon⁽³⁾,
Hyung Jin Kim⁽⁴⁾
(1) Wonkwang Univeristy, IKsan, Kyung Hee University, Seoul,
(2) Kyungpook National University, Daegu,
(3) Ulsan University, Ulsan,
(4) Chonbuk National Universitym Jeonju

P-36

Diagnostic Accuracy of MRI targeted vs random systematic biopsies for detection of significant volume prostate cancer
Haffner J., Villers A., Puech Ph., Potiron E., Lemaitre C., Leroy X., Biserte J., Lemaitre L.
Department of Urology, Lille University, Lille, France

P-37
Can the conventional sextant prostate biopsy reliably diagnose unilateral prostate cancer in low-risk localized prostate cancer?
Mayes J. M., Mouraviev V., Sun L.1, Madden J. F., Polascik T. J.
Duke University Medical Center, Durham, USA

P-38
Predicting unilaterality of prostate cancer on biopsy: Sextant versus extended
Tsivian M., Kimura M., Sun L., Mouravivev V., Mayes J.M., Moul J.W., Polascik Th.J.
Duke University Medical Center, Durham NC, USA

P-39
Template Transperineal Prostate Mapping Biopsies for Prostate Cancer Risk Stratification and Cancer Localisation
Ahmed H.U.⁽¹⁾, Stevens D.⁽¹⁾, Barbouti O.⁽¹⁾, Sahu M.⁽¹⁾, Arumainayagam N.⁽¹⁾, Govindaraju, S.⁽¹⁾ ,Freeman, A.⁽²⁾, Emberton M.⁽¹⁾
(1) Division of Surgery and Interventional Sciences, University College London, UK
(2) Department of Histology, UCLH Foundation NHS Trust, London, UK

P-40
Free hand 3D-Trus prostate biopsies mapping
Mozer P.⁽¹⁾, Baumann M.⁽²⁾, Chevreau G.^(1,2), Daanen V.⁽³⁾, Renard-Penna R.⁽⁴⁾,
Troccaz J.⁽²⁾
(1) Department of Urology, Pitié-Salpêtrière Hospital, Pierre et Marie Curie University (Paris VI) Paris, France.
(2) TIMC Laboratory, IN3S, Faculté de Médecine, Domaine de la Merci, 38706 La Tronche Cedex, France.
(3) KOELIS© - www.koelis.com
(4) Department of Radiology, Pitié-Salpêtrière Hospital, Pierre et Marie Curie University (Paris VI) Paris, France

P-41
Conventional prostate biopsy predicts the laterality of dominant disease among men with bilateral prostate cancer on radical prostatectomy (RP)
Dakwar G., Tareen B., Lepor H., Taneja S. S.
New York University Department of Urology, Beth Israel Medical Center Department of Urology, New York, NY, USA

P-42
Acoustic radiation force impulse (ARFI) imaging of human prostate in vivo
Zhai L.⁽¹⁾, Mouraviev V.⁽²⁾, Madden J. F.⁽³⁾, Polascik T. J.⁽²⁾, Nightingale K.⁽¹⁾
(1) Department of Biomedical Engineering,

(2) Department of Surgery,

(3) Department of Pathology, Duke University Medical Center, Durham, NC, USA

P-43
Molecular imaging of prostate cancer in vivo using a targeted contrast agent in intermolecular multiple-quantum coherences MRI experiments
Mouraviev V.⁽¹⁾, Branca R. T.⁽²⁾, Andrews R.⁽¹⁾, Tsivian M.⁽¹⁾, Sullivan D. S.⁽³⁾,
Leuschner C.⁽⁴⁾, Kumar C.⁽⁴⁾, Warren W. S.⁽²⁾, Polascik T. J.⁽¹⁾
(1) Duke Prostate Center, Duke Medical University Center,

(2) Duke University, NC,

(3) Duke Comprehensive Cancer Center, NC,
(4) Louisiana State University, LU, USA

P-44

Prostate Cancer Detection: biopsy findings based on tissue alterations in real time Elastography and T2 weighted endorectal magnetic resonance imaging
Pallwein L.⁽¹⁾, Aigner F.⁽¹⁾, Horninger W.⁽²⁾, Schocke M.⁽¹⁾, Frauscher F.⁽¹⁾
(1) Dept. of Radiology, Innsbruck, Austria,

(2) Dept. of Urology, Innsbruck, Austria

P-45
Image registration for guiding biopsy and focal therapy of prostate cancer
Hu Y.⁽¹⁾, Ahmed H.U.⁽²⁾, Allen C.⁽³⁾, Pendsé D.⁽³⁾, Sahu M.⁽²⁾, Emberton M.⁽²⁾,
Carter T.J.⁽¹⁾, Hawkes D.J.⁽¹⁾, Barratt D.C.⁽¹⁾
(1) Centre for Medical Image Computing, University College London, London, UK,

(2) Department of Urology, Division of Surgery & Interventional Science, University College London, London, UK,

(3) Department of Radiology, University College London Hospital (UCLH), London, UK

P-46
Contrast enhanced transrectal ultrasound imaging (CETRUS) - possible correlation with histology
Witzsch U., Hieronymi S., Voss G., Becht E.
Klinik fur Urologie und Kinderurologie, Krankenhaus Nordwest, Frankfurt, Germany

P-47
Potential role of prostate histoscanning in focal therapy
Kumaar S.⁽¹⁾ , Ahmed H.U.⁽¹⁾, Tuernicht K.⁽²⁾, Jarmulowicz M.⁽²⁾, Bleiberg H.⁽³⁾, Braeckman J.⁽⁴⁾, Michielson D.⁽⁴⁾, Romics I.⁽⁵⁾, Zatura F.⁽⁶⁾, Peltier A.⁽⁷⁾, Autier P.⁽⁸⁾, Emberton M.⁽¹⁾
(1) University College London, Division of Surgery and Interventional Sciences, London, United Kingdom,

(2) Bostwick Laboratory, London, United Kingdom,

(3) Advanced Medical Diagnostics, Medical Affairs, Waterloo, Belgium,

(4) Universiteit Hospital Brussels, Dept. of Urology, Brussels, Belgium,

(5) Semmelweis Medical University, Dept. of Urology, Budapest, Hungary,

(6) Faculty Hospital Olomouc, Dept. of Urology, Czech Republic,

(7) Institut Jules Bordet Brussels, Urology, Brussels, Belgium,

(8) International Agency for Research on Cancer, Lyon, France

P-48
Multiphoton microscopy imaging of periprostatic tissue architecture for improving clinicopathologic outcomes of nerve-sparing radical prostatectomy: initial results from ex vivo rat and human prostatectomy models
Tan G.Y., Herman M.P., Yadav R., Mukherjee S., Maxfield F.R., Webb W.W., Tewari A.K.
Weill Medical College of Cornell University, New York, USA

P-49

Prostate MRI for cancer localization - What are we missing?
Langer D.L.^(1,2), van der Kwast T.H.⁽³⁾, Evans A.J.⁽³⁾, Trachtenberg J.⁽⁴⁾, Wilson B.C.⁽⁵⁾, Haider M.A.^(1,2)
(1) Joint Department of Medical Imaging, Princess Margaret Hospital, University Health Network and Mount Sinai Hospital, Toronto, Ontario, Canada.

(2) Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada.

(3) Department of Pathology and Laboratory Medicine, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.

(4) Department of Surgical Oncology, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada.

(5) Medical Biophysics, University of Toronto, Ontario Cancer Institute, Toronto, Ontario, Canada

P-50

Can MRI improve the predictive ability of biopsy in identifying men for hemiablative focal therapy?
Basir Tareen, Timothy Ito, Guilherme Godoy, George Dakwar, Bachir Taouli, Samir S. Taneja
New York University Department of Urology, Beth Israel Medical Center Department of Urology, New York, USA

P-51

Feasibility of MR spectroscopy (1H-MRS) for the evaluation of recurrence after the targeted focal therapy (TFT) with High-Intensity Focused Ultrasound (HIFU) in the treatment of localized prostate cancer
Satoru Muto, Keisuke Saito, Hisamitsu Ide, Shigeo Horie
Department of Urology, Teikyo University, Tokyo, Japan

P-52

Multi-functional mri using dynamic contrast enhancement and diffusion weighting to detect localised recurrence in radio-recurrent prostate cancer
Arumainayagam N.⁽¹⁾, Ahmed H.U.⁽¹⁾, Kumaar S.⁽¹⁾, Sahu M.⁽¹⁾, Illing R.O.⁽²⁾, Moore C.M.⁽¹⁾, Payne H.⁽³⁾, Freeman A.⁽⁴⁾, Allen C.⁽²⁾, Kirkham A.⁽²⁾, Emberton M.⁽¹⁾
(1) The Division of Surgery and Interventional Sciences, University College London, UK;
(2) The Department of Radiology, University College Hospital, London, UK;

(3) The Department of Oncology, University College Hospital, London, UK;

(4) The Department of Histopathology, University College Hospital, London, UK

P-53
Contrast-ultrasound diffusion imaging of the prostate
Kuenen, M.P.J.⁽¹⁾, Wijkstra, H.⁽²⁾, Hendrikx A.J.⁽³⁾, Mischi M.⁽¹⁾
(1) Dept. of Electrical Engineering, Eindhoven University of Technology, the Netherlands,

(2) Dept. of Urology Research, Academic Medical Center, Amsterdam, the Netherlands,

(3) Dept of Urology, Catharina Hospital, Eindhoven, the Netherlands

P-54

8 and 12 core TRUS guided PBPs achieve similar PCa detection
Mamoulakis C.⁽¹⁾, de la Rosette J.J.⁽¹⁾, Laguna M.P.⁽¹⁾, Wink M.H.⁽¹⁾, Wondergem N.⁽¹⁾, ten Kate F.J.C.⁽²⁾, Zwinderman K.⁽³⁾, de Reijke T.M.⁽¹⁾, Wijkstra H.⁽¹⁾
Department of Urology (1), Pathology (2), and Epidemiology (3), AMC University Hospital, Amsterdam, The Netherlands

P-55

MRI Guided Needle Navigation in Prostate Cancer Targeting
Suljendic D.⁽¹⁾, Lee J.⁽¹⁾, Chopra S.⁽¹⁾, Kirilova A.⁽¹⁾, Publicover J.⁽¹⁾, Abed J.⁽¹⁾, Haider M.⁽¹⁾, Krieger A.⁽²⁾, Fichtinger G.⁽³⁾, Brock K.⁽¹⁾, Menard C.⁽¹⁾
(1) Princess Margaret Hospital, Toronto, Canada

(2) Sentinelle Medical, Toronto, Canada

(3) Queen's University, Kingston, Canada

Poster Session IV
Prostate Treatment-Focal Therapies

Hall Nassau Zaal

Moderators: Christian Chaussy (DE) - Thomas Polascik (USA)

P-56

Is focal therapy of localized prostate cancer feasible in the United Kingdom? A histopathological analysis of tumour characteristics and the index lesion
Karavitakis M.⁽²⁾, Beckley I.⁽¹⁾, Livni N.⁽¹⁾, Abel P.^(1,2), Winkler M.^(1,2), Ahmed H.U.^(1,3)
(1) Imperial College Healthcare NHS Trust, London, UK,

(2) Imperial College London, UK,

(3) Division of Surgery and Interventional Sciences, University College London, UK

P-57

Is there a role for Index Lesion Ablation in Focal Therapy of Prostate Cancer?
Sahu M.⁽¹⁾, Ahmed H.U.⁽¹⁾, Kumaar S.⁽¹⁾, Arumainayagam N.⁽¹⁾, Rogers K.⁽¹⁾, Kirkham A.⁽²⁾, Freeman A.⁽³⁾, Allen C.⁽²⁾, Emberton M.⁽¹⁾
(1) Division of Surgery and Interventional Sciences, University College London, UK,
(2) Department of Radiology, University College London Hospital, UK,

(3) Department of Histopathology, University College London Hospital, UK

P-58

Is it sufficient to treat index lesion alone in multifocal prostate cancer?
Kumaar S.⁽¹⁾, Ahmed H.U.⁽¹⁾, Sahu M.⁽¹⁾, Arumainayagam N.⁽¹⁾, Treurnicht K.⁽²⁾, Jarmulowicz M.⁽²⁾, Emberton M.⁽¹⁾
(1) Division of Surgery and Interventional Science, University College London, UK
(2) Bostwick Laboratories, London , UK

P-59

Pulsed dose-rate (PDR) brachytherapy boost for intermediate to high-risk prostate cancer
Pieters B.R., Blank L.E.C.M., Geijsen E.D., van der Grient J.N.B., Koedooder C., de Reijke Th.M.
Departments of Urology and Radiotherapy, AMC University Hospital, Amsterdam, The Netherlands

P-60

Cyberknife stereotactic radiotherapy as monotherapy for early stage prostate cancer: The Rotterdam experience
Aluwini S.⁽¹⁾, Van Rooij P.⁽¹⁾, Hoogeman M.⁽¹⁾, Bangma C.⁽²⁾, Kolkman-Deurloo I.K.⁽¹⁾
(1) Erasmus MC,

(2) Daniel den Hoed Cancer Center, Rotterdam, Radiation Oncology department

P-61

HDR brachytherapy as monotherapy for early stage prostate cancer: The Rotterdam experience
Aluwini S.⁽¹⁾, van Rooij P.⁽¹⁾, Kirkels W. J.⁽²⁾, Bangma C. ⁽²⁾, Kolkman-Deurloo I.K.⁽¹⁾
(1) Erasmus MC,

(2) Daniel den Hoed Cancer Center, Rotterdam, Radiation Oncology department

P-62

Prostate histotripsy: non-thermal mechanical tissue ablation
Roberts W.W., Hempel C.R., Hall T.L., Wheat J.C., Fowlkes J.B., Xu Z., Cain C.A.
Departments of Urology and Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA

P-63

A Phase II Trial assessing the role of Focal Ablation using HIFU in Localised Prostate Cancer: interim results
Sahu M.⁽¹⁾, Ahmed H.U.⁽¹⁾, Kumaar S.⁽¹⁾, Arumainayagam N.⁽¹⁾,
Rogers K.⁽¹⁾, Scott R.⁽¹⁾, Kirkham A.⁽²⁾, Freeman A.⁽³⁾, Allen C.⁽²⁾, Emberton M.⁽¹⁾
(1) Division of Surgery and Interventional Sciences,

(2) Department of Radiology, UCLH Foundation NHS Trust, University College London, UK,

(3) Department of Histology, UCLH Foundation NHS Trust, UK

P-65

A Phase II Trial assessing the role of Focal Ablation using HIFU in Localised Prostate Cancer: interim results
Sahu M.⁽¹⁾, Ahmed H.U.⁽¹⁾, Kumaar S.⁽¹⁾, Arumainayagam N.⁽¹⁾, Rogers K.⁽¹⁾,
Scott R.⁽¹⁾, Kirkham A.⁽²⁾, Freeman A.⁽³⁾, Allen C.⁽²⁾, Emberton M.⁽¹⁾
(1) Division of Surgery and Interventional Sciences,

(2) Department of Radiology, UCLH Foundation NHS Trust, University College London, UK,

(3) Department of Histology, UCLH Foundation NHS Trust, UK

P-66

Neoadjuvant androgen suppression in high intensity focused ultrasound therapy for localized prostate cancer
Wansuk Kim, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Hyun Moo Lee
Samsung Medical Center, Seoul, Korea

P-67

Feasibility of focal salvage hifu for prostate cancer recurrence
Kumaar S.⁽¹⁾, Ahmed H.U.⁽¹⁾, Arumainanayam N.⁽¹⁾, Sahu M.⁽¹⁾,
Freeman A.⁽²⁾, Kirkham A.⁽³⁾, Allen C.⁽³⁾, Emberton M.⁽¹⁾
(1) Division of Surgery and Interventional Science, University College London,

(2) Department of Histology, UCLH NHS Foundation Trust

(3) Department of Radiology, UCLH NHS Foundation Trust, UK

P-68

Focal therapy with HIFU for prostate cancer in elderly: feasibility study with 10 years follow up
Barret E., Prapotnich D., Cathelineau X., Rozet F., Vallancien G.
Department of urology, Institut Montsouris, Universite Paris Descartes, Paris, France

P-69

Prostate cryoablation as primary treatment of prostate cancer: oncological results with follow-up biopsy
Galosi A.B.⁽¹⁾, Parri G.⁽¹⁾, Montironi R.⁽²⁾, Lugnani F.⁽³⁾,
Cantoro D.⁽¹⁾, Muzzonigro G.⁽¹⁾
(1) Institute of Urology,

(2) Institute of Pathological Anatomy and Histopathology, Polytechnic University of Marche Region, Torrette United Hospitals, Ancona,

(3) International Society of Cryosurgery, Villa Salus, Trieste, Italy

P-70

Initial experience of photodynamic therapy in prostate cancer patients
Alekseev B.Y., Bystrov S.V., Rusakov I.G., Sokolov V.V., Chissov V.I.
Moscow Hertzen Oncology Institute, Moscow, Russia

P-71

Third-Generation Cryosurgery of Prostate Cancer: Initial Dutch Results
Vergunst H., Broers E.M.P., Langenhuijsen J. F.
Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands

P-72

Salvage cryotherapy for radio recurrent prostate cancer
Mevcha A., Kumar V., Probert J., Gillatt D.
Bristol Urology Institute, Southmead Hospital, Bristol, UK

P-73

WST-09 Mediated photodynamic therapy for prostate cancer
Arumainayagam N.⁽¹⁾, Ahmed H.U.⁽¹⁾, Sahu M.⁽¹⁾, Pendse D.⁽²⁾,
Moore C.M.⁽¹⁾, Allen C.⁽²⁾, Mosse A.M.⁽³⁾, Bown S.G.⁽³⁾, Emberton M.⁽¹⁾
(1) The Division of Surgery and Interventional Sciences, Univeristy College,

(2) The Department of Radiology, University College London Hospital,

(3) National Medical Laser Centre, University College London, London, UK

P-74

WST-11 Mediated photodynamic therapy for prostate cancer
Arumainayagam N.⁽¹⁾, Moore C.M.⁽¹⁾, Ahmed H.U.⁽¹⁾, Sahu M.⁽¹⁾,
Kumaar S.⁽¹⁾, Pendse D.⁽²⁾, Mosse A.M.⁽³⁾, Allen C.⁽²⁾, Bown S.G.⁽³⁾,
Emberton M.⁽¹⁾

(1) The Division of Surgery and Interventional Sciences, Univeristy College London, UK,

(2) The Department of Radiology, University College London Hospital, London, UK,
(3) National Medical Laser Centre, University College London, London, UK

P-75

Robot-Assisted MRI-Guided Prostatic Interventions
Lindner U.⁽¹⁾, Goldenberg A.⁽²⁾, Haider M.A.⁽¹⁾, Kucharczyk W.⁽¹⁾,
Sussman M.⁽¹⁾, Yi Y.⁽²⁾, Ma L.⁽²⁾, Trachtenberg J.⁽²⁾
(1) Princess Margaret Hospital, University Health Network, Toronto, ON, Canada
(2) Engineering Services Inc. Toronto, Canada

P-76

Are Men Diagnosed With Prostate Cancer on Repeat Biopsy Better Candidates for Active Surveillance than Men Diagnosed on First Biopsy?
Abraham N., Lepor H., Taneja S.S.
New York University Department of Urology, New York, USA

Non - Discussion Posters

Wintertuin Foyer

P-77

The change of quality of life due to urinary symptoms after treatment of lutenizing hormone releasing hormone agonist leuprolide acetate for patients with severe BPH
Jung Moon Heo
Busan Veterans Hospital, Busan, Korea, Urology, Busan, Korea

P-78

The comparison between efficacy of Tamsulosin and Terazosinin alpha-adrenergic blockers after ESWL (A double blind clinical trial)
Tajari H. Pedram P.M., Keshtkar A.A., Ghazi Moghadam B., Amidi A.
Gorgan University of medical sciences, Gorgan, Iran

P-79

Plasma membrane markers for papillary renal cell carcinoma
Sanford T., Linehan W.M., Bratslavsky B.
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA

P-80

Laparascopic Surgery of Primary Renal Lymphoma
Siavash Falahatkar, Seyedeh Atefeh Emadi, Marzieh Akbarpour
Guilan University of Medical Sciences,Urology research Center, Rasht, Iran

P-81

Standard, hand-assisted and robot assisted laparoscopic partial nephrectomy in T1 renal tumors: group Florence Nightingale experience
Kural A.R., Tufek I., Akpinar H., Atug F.
Bilim University, Florence Nightingale Hospital, Istanbul, Turkey

P-82

Sarcomatoid renal cancer. A case report
Sotiropoulou G.⁽¹⁾, Xoxakos I.⁽²⁾, Chatzinicolaou V.⁽¹⁾, Rompolis D.⁽²⁾,
Kalyvas Ch.⁽²⁾, Louka G.⁽²⁾, Stokidis D.⁽²⁾
(1) Department of Pathology, General Hospital of Korinthos,Greece
(2) Department of Urology, General Hospital of Korinthos,Greece

P-83
Development and evaluation of a transrectal ultrasound (TRUS)
Crouzet S., Kamoi K., Kaouk J.H., Gill I.S., Haber G.P.
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, USA

P-84
Incomplete obstructive ileum as first event of locally advanced prostate cancer
Daligkaros G., Kikidakis D., Kiryttopoulos P.
Department of urology, General Hospital of Veria, Greece

P-85
Contrast enhanced transrectal ultrasound imaging - Identifying patterns
Witzsch U., Hieronymi S., Becht E.
Klinik fur Urologie und Kinderurologie, Krankenhaus Nordwest, Frankfurt, Germany

P-86
Assessment of Atorvastatin effectiveness on serum PSA level in hypercholestrolemic males
Falahatkar S., Khosropanah I., Panahandeh Z., Farhat B.
Guilan University of Medical Sceinces, Urology Research Center, Rasht, Iran

P-87
Primary signet ring cell carcinoma of the prostate
Xoxakos I.⁽¹⁾, Sotiropoulou G.⁽²⁾, Rompolis D.⁽¹⁾,
Chatzinicolaou V.⁽²⁾, Kalyvas Ch.⁽¹⁾, Stokidis D.⁽¹⁾
(1) Department of Urology, General Hospital of Korinthos,Greece
(2) Department of Pathology, General Hospital of Korinthos,Greece

P-88
CLL and leukaemic infiltration of the prostate
Rompolis D.⁽¹⁾, Xoxakos I.⁽¹⁾, Sotiropoulou G.⁽²⁾, Chatzinicolaou V.⁽²⁾, Kalyvas Ch.⁽¹⁾, Stokidis D.⁽¹⁾
(1) Department of Urology, General Hospital of Korinthos,Greece
(2) Department of Pathology, General Hospital of Korinthos,Greece

P-89

Is focal salvage therapy possible in prostate ca recurrence?
Kumaar S.⁽¹⁾, Ahmed H.U.⁽¹⁾, Sahu M.⁽¹⁾, Arumainayagam N.⁽¹⁾,
Freeman A.⁽²⁾, Emberton M.⁽¹⁾
(1) Division of Surgery and Interventional Science, University College London
(2) Department of Histopathology, University College London Hospitals NHS Trust, London, UK

P-90
Synchronous primary prostate and urinary bladder cancer
Xoxakos I.⁽¹⁾, Sotiropoulou G.⁽²⁾, Chatzinikolaou V.⁽²⁾,
Rombolis D.⁽¹⁾, Kalyvas C.⁽¹⁾, Stokidis D.⁽¹⁾
(1) Urology department-G.H.Korinthos-Greece,

(2) Pathology department- G.H.Korinthos-Greece

P-91
Uiss and ssign scores in asian patients with renal cell carcinoma
Wu F.⁽¹⁾, Huang H.H.⁽¹⁾, Tan M.H.⁽²⁾, Chong T.W.⁽¹⁾
(1) Dept of Urology, Singapore General Hospital;

(2) Medical Oncology, National Cancer Centre Singapore

PLATINUM SPONSOR

GOLD SPONSORS

SILVER SPONSORS

BRONZE SPONSORS

CONTRIBUTORS

Top